Physician profile
Roland E Siegler
NPI 1306832761
$1,253.28
in general payments reported to CMS, 2019-2025
19 companies · $13.79 in 2025
The $13.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.02 · 2020: $293 · 2021: $224 · 2022: $155 · 2023: $416 · 2024: $67.68 · 2025: $13.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.23 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $160.87 | 2023 | |
| Novo Nordisk INC | $155.84 | 2020-2023 | Rybelsus |
| Lilly USA, LLC | $147.42 | 2020-2024 | Mounjaro, Jardiance, Trulicity |
| Merck Sharp & Dohme LLC | $118.20 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.38 | 2019-2023 | Jardiance |
| Allergan, INC. | $58.91 | 2019-2020 | |
| Glaxosmithkline, LLC. | $54.50 | 2019-2024 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $38.50 | 2019-2020 | |
| Eisai INC. | $36.00 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $29.80 | 2020 | |
| Astellas Pharma US INC | $29.59 | 2024-2025 | Veozah |
| Genentech USA, INC. | $26.77 | 2019-2020 | |
| Abbott Laboratories | $24.98 | 2023 | Freestyle Libre 2 |
| Exact Sciences Corporation | $23.03 | 2023 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.73 | 2021 | |
| Medtronic, INC. | $16.33 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.03 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.17 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roland Siegler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.